Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 6/2008

01-08-2008

Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease

Auteurs: Sara N. Davison, Gian S. Jhangri, David H. Feeny

Gepubliceerd in: Quality of Life Research | Uitgave 6/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

This study assessed the construct validity of the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) in the context of chronic kidney disease (CKD) and compared their ability to discriminate between groups of patients with varying disease severity.

Study design and setting

The HUI2 and HUI3 were correlated with the Medical Outcomes 36-Item Short-Form, Kidney Disease Quality of Life Questionnaire, and the Beck Depression Inventory II in 185 patients with stage 4 and 5 CKD.

Results

About 86% of a priori hypotheses were confirmed for HUI2 and 95% for HUI3, providing support for the construct validity of both measures. Mean (SD) overall utility score for the HUI2 was 0.74 (0.20), significantly higher than that for the HUI3, 0.58 (0.26) (P < 0.001). The cognitive, emotion, and pain attributes of the HUI3 were able to identify a significantly greater proportion of patients with impairment compared to the HUI2.

Conclusion

The results are consistent with construct validity for the HUI2 and HUI3 in patients with stage 4 and 5 CKD. However, the HUI3 appears to have superior psychometric properties compared with the HUI2 in this patient population.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference DeOreo, P. B. (2001). The use of patient-based instruments to measure, manage, and improve quality of care in dialysis facilities. Advances in Renal Replacement Therapy, 8(2), 125–130. PubMedCrossRef DeOreo, P. B. (2001). The use of patient-based instruments to measure, manage, and improve quality of care in dialysis facilities. Advances in Renal Replacement Therapy, 8(2), 125–130. PubMedCrossRef
2.
go back to reference Ifudu, O., Paul, H. R., Homel, P., & Friedman, E. A. (1998). Predictive value of functional status for mortality in patients on maintenance hemodialysis. American Journal of Nephrology, 18(2), 109–116. PubMedCrossRef Ifudu, O., Paul, H. R., Homel, P., & Friedman, E. A. (1998). Predictive value of functional status for mortality in patients on maintenance hemodialysis. American Journal of Nephrology, 18(2), 109–116. PubMedCrossRef
3.
go back to reference McClellan, W. M., Anson, C. A., Birkeli, K., & Tuttle, E. (1991). Functional status and quality of life: Predictors of early mortality among patients entering treatment for end stage renal disease. Journal of Clinical Epidemiology, 44(1), 83–89. PubMedCrossRef McClellan, W. M., Anson, C. A., Birkeli, K., & Tuttle, E. (1991). Functional status and quality of life: Predictors of early mortality among patients entering treatment for end stage renal disease. Journal of Clinical Epidemiology, 44(1), 83–89. PubMedCrossRef
4.
go back to reference Hays, R. D. (1998). R36 H.S.I. Rand 36—36 health status inventory. Harcourt Brace & Company. Hays, R. D. (1998). R36 H.S.I. Rand 36—36 health status inventory. Harcourt Brace & Company.
5.
go back to reference Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., Amin, N., Carter, W. B., et al. (1997). Kidney disease quality of life short form (dkqol-sf), version 1.3: A manual for use and scoring. Santa Monica, CA: RAND. Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., Amin, N., Carter, W. B., et al. (1997). Kidney disease quality of life short form (dkqol-sf), version 1.3: A manual for use and scoring. Santa Monica, CA: RAND.
6.
go back to reference Annual Data Report. (2007). Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases, 49(Supplement 1), S1–S239. Annual Data Report. (2007). Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases, 49(Supplement 1), S1–S239.
7.
go back to reference Trivedi, H. S., Pang, M. M., Campbell, A., & Saab, P. (2002). Slowing the progression of chronic renal failure: Economic benefits and patients’ perspectives. American Journal of Kidney Diseases, 39(4), 721–729. PubMedCrossRef Trivedi, H. S., Pang, M. M., Campbell, A., & Saab, P. (2002). Slowing the progression of chronic renal failure: Economic benefits and patients’ perspectives. American Journal of Kidney Diseases, 39(4), 721–729. PubMedCrossRef
8.
go back to reference Lenert, L., & Kaplan, R. M. (2000). Validity and interpretation of preference-based measures of health-related quality of life. Medical Care, 38(9 Suppl), II138–II150. PubMed Lenert, L., & Kaplan, R. M. (2000). Validity and interpretation of preference-based measures of health-related quality of life. Medical Care, 38(9 Suppl), II138–II150. PubMed
9.
go back to reference Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189. PubMedCrossRef Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189. PubMedCrossRef
10.
go back to reference Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128. PubMedCrossRef Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128. PubMedCrossRef
11.
go back to reference Feeny, D., Torrance, G. W., & Furlong, W. (1996). Quality of life and pharmacoeconomics in clinical trials. In B. Spilker (Ed.), Health utilities index (pp. 239–51). Philadelphia, PA: Lippincort-Raven. Feeny, D., Torrance, G. W., & Furlong, W. (1996). Quality of life and pharmacoeconomics in clinical trials. In B. Spilker (Ed.), Health utilities index (pp. 239–51). Philadelphia, PA: Lippincort-Raven.
12.
go back to reference Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33(5), 375–384. PubMedCrossRef Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33(5), 375–384. PubMedCrossRef
13.
go back to reference Torrance, G. W., Feeny, D. H., Furlong, W. J., Barr, R. D., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Medical Care, 34(7), 702–722. PubMedCrossRef Torrance, G. W., Feeny, D. H., Furlong, W. J., Barr, R. D., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Medical Care, 34(7), 702–722. PubMedCrossRef
14.
go back to reference Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. PubMedCrossRef Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. PubMedCrossRef
15.
go back to reference Ware, J. E. (1993). SF-36 Health survey: Manual and interpretation guide. Boston, MA: New England Medical Centre. Ware, J. E. (1993). SF-36 Health survey: Manual and interpretation guide. Boston, MA: New England Medical Centre.
16.
go back to reference Beck, A. T., Steer, R. A., & Brown, G. K. (1996). BDI-II manual (2nd ed.). San Antonio, Texas: Harcourt Brace. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). BDI-II manual (2nd ed.). San Antonio, Texas: Harcourt Brace.
17.
go back to reference Kimmel, P. L. (2001). Psychosocial factors in dialysis patients. Kidney International, 59(4), 1599–1613. PubMedCrossRef Kimmel, P. L. (2001). Psychosocial factors in dialysis patients. Kidney International, 59(4), 1599–1613. PubMedCrossRef
18.
go back to reference Newmann, S. P. (2002). A randomised controlled trial of a psychological intervention to promote emotional expression and adaptation in individuals with chronic renal failure (CRF) and end stage renal disease (ESRD). UK: National Research Registry. Newmann, S. P. (2002). A randomised controlled trial of a psychological intervention to promote emotional expression and adaptation in individuals with chronic renal failure (CRF) and end stage renal disease (ESRD). UK: National Research Registry.
19.
go back to reference Kimmel, P. L. (2000). Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes. American Journal of Kidney Diseases, 35(4), S132–S140. PubMedCrossRef Kimmel, P. L. (2000). Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes. American Journal of Kidney Diseases, 35(4), S132–S140. PubMedCrossRef
20.
go back to reference Zimmermann, P. R., Camey, S. A., & Mari, J. J. (2006). A cohort study to assess the impact of depression on patients with kidney disease. International Journal of Psychiatry in Medicine, 36(4), 457–468. PubMedCrossRef Zimmermann, P. R., Camey, S. A., & Mari, J. J. (2006). A cohort study to assess the impact of depression on patients with kidney disease. International Journal of Psychiatry in Medicine, 36(4), 457–468. PubMedCrossRef
21.
go back to reference Hedayati, S. S., Bosworth, H. B., Kuchibhatla, M., Kimmel, P. L., & Szczech, L. A. (2006). The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International, 69(9), 1662–1668. PubMedCrossRef Hedayati, S. S., Bosworth, H. B., Kuchibhatla, M., Kimmel, P. L., & Szczech, L. A. (2006). The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International, 69(9), 1662–1668. PubMedCrossRef
22.
go back to reference Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. PubMedCrossRef Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. PubMedCrossRef
23.
go back to reference Van Manen, J. G., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., & Krediet, R. T. (2003). Adjustment for comorbidity in studies on health status in ESRD patients: Which comorbidity index to use? Journal of the American Society of Nephrology, 14(2), 478–485. PubMedCrossRef Van Manen, J. G., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., & Krediet, R. T. (2003). Adjustment for comorbidity in studies on health status in ESRD patients: Which comorbidity index to use? Journal of the American Society of Nephrology, 14(2), 478–485. PubMedCrossRef
24.
go back to reference Beddhu, S., Bruns, F. J., Saul, M., Seddon, P., & Zeidel, M. L. (2000). A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. The American Journal of Medicine, 108(8), 609–613. PubMedCrossRef Beddhu, S., Bruns, F. J., Saul, M., Seddon, P., & Zeidel, M. L. (2000). A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. The American Journal of Medicine, 108(8), 609–613. PubMedCrossRef
25.
go back to reference Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Willey. Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Willey.
26.
go back to reference Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773–778. PubMedCrossRef Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773–778. PubMedCrossRef
27.
go back to reference Birbeck, G. L., Kim, S., Hays, R. D., & Vickrey, B. G. (2000). Quality of life measures in epilepsy: how well can they detect change over time? Neurology, 54(9), 1822–1827. PubMed Birbeck, G. L., Kim, S., Hays, R. D., & Vickrey, B. G. (2000). Quality of life measures in epilepsy: how well can they detect change over time? Neurology, 54(9), 1822–1827. PubMed
28.
go back to reference Johnson, J. A., & Maddigan, S. L. (2004). Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Quality of Life Research, 13(2), 449–456. PubMedCrossRef Johnson, J. A., & Maddigan, S. L. (2004). Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Quality of Life Research, 13(2), 449–456. PubMedCrossRef
29.
go back to reference Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404. PubMedCrossRef Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404. PubMedCrossRef
30.
go back to reference Canadian Organ Replacement Register. (2002). Dialysis and renal transplantation. Ottawa, Ontario: Canadian Institute for Health Information. Report No.: 2001 Report. Canadian Organ Replacement Register. (2002). Dialysis and renal transplantation. Ottawa, Ontario: Canadian Institute for Health Information. Report No.: 2001 Report.
31.
go back to reference Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., et al. (2000). Canadian normative data for the SF-36 health survey. CMAJ, 163(3), 265–271. PubMed Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., et al. (2000). Canadian normative data for the SF-36 health survey. CMAJ, 163(3), 265–271. PubMed
32.
go back to reference Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629. PubMed Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629. PubMed
33.
go back to reference Gorodetskaya, I., Zenios, S., McCulloch, C. E., Bostrom, A., Hsu, C. Y., Bindman, A. B., et al. (2005). Health-related quality of life and estimates of utility in chronic kidney disease. Kidney International, 68(6), 2801–2808. PubMedCrossRef Gorodetskaya, I., Zenios, S., McCulloch, C. E., Bostrom, A., Hsu, C. Y., Bindman, A. B., et al. (2005). Health-related quality of life and estimates of utility in chronic kidney disease. Kidney International, 68(6), 2801–2808. PubMedCrossRef
34.
go back to reference Foley, R. N., Parfrey, P. S., Morgan, J., Barre, P. E., Campbell, P., Cartier, P., et al. (2000). Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International, 58(3), 1325–1335. PubMedCrossRef Foley, R. N., Parfrey, P. S., Morgan, J., Barre, P. E., Campbell, P., Cartier, P., et al. (2000). Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International, 58(3), 1325–1335. PubMedCrossRef
35.
go back to reference Heidenheim, A. P., Muirhead, N., Moist, L., & Lindsay, R. M. (2003). Patient quality of life on quotidian hemodialysis. American Journal of Kidney Diseases, 42(1 Suppl), 36–41. PubMedCrossRef Heidenheim, A. P., Muirhead, N., Moist, L., & Lindsay, R. M. (2003). Patient quality of life on quotidian hemodialysis. American Journal of Kidney Diseases, 42(1 Suppl), 36–41. PubMedCrossRef
36.
go back to reference Davison, S. N., Jhangri, G. S., & Feeny, D. (2008). Comparing the health utilities index mark 3 (HUI3) with the short-form 36 preference-based SF-6D in chronic kidney disease. Value in Health (in press). Davison, S. N., Jhangri, G. S., & Feeny, D. (2008). Comparing the health utilities index mark 3 (HUI3) with the short-form 36 preference-based SF-6D in chronic kidney disease. Value in Health (in press).
Metagegevens
Titel
Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease
Auteurs
Sara N. Davison
Gian S. Jhangri
David H. Feeny
Publicatiedatum
01-08-2008
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 6/2008
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-008-9354-1